FRINK Linked Data Fragments server

Matches in SemOpenAlex for { <https://semopenalex.org/work/W2581748696> ?p ?o ?g. }

• W2581748696 abstract "Abstract Abstract 2177 The antiapoptotic function of the inhibitors of apoptosis family of proteins (IAPs) is antagonized by mitochondria-released SMAC protein. The IAP-member XIAP suppresses apoptosis by directly binding and inhibiting caspase-9 and caspase-3, while cIAP1, a component of the cytoplasmic signaling complex containing TNF receptor associated factors, suppresses apoptosis via the caspase-8-mediated pathway. BV-6 (Genentech) is a bivalent SMAC-mimetic and has been shown to promote cell death by inducing cIAP autoubiquitination, NF-κB activation, and TNFα-dependent apoptosis. We examined its effect on leukemic cells and found that BV-6 only moderately induced apoptosis. The EC50 was found to be 15.3±5.1 μM at 48 hours in OCI-AML3 cells which are relatively sensitive. We then determined whether BV-6 sensitizes leukemic cells to the HDM2-inhibitor nutlin-3a and to Ara-C. p53 modulates the expression and activity of Bcl-2 family proteins and promotes the mitochondrial-mediated apoptosis. We showed previously that activation of p53 by nutlin-3a sensitizes AML cells to XIAP inhibition induced-death in part by promoting the release of SMAC from mitochondrion (Carter BZ et al., Blood 2010). We treated OCI-AML3 cells with BV-6, nutlin-3a or Ara-C, and BV-6+nutlin-3a or BV-6+Ara-C and found that the combination of BV-6 and nutlin-3a or BV-6 and Ara-C synergistically induced cell death in OCI-AML3 cells with a combination index (CI) of 0.27±0.11 and 0.22±0.05 (48 hours), respectively. To demonstrate that p53 activation is essential for the synergism of BV-6+nutlin-3a combination, we treated OCI-AML3 vector control and p53 knockdown cells with these two agents and found that the combination synergistically promoted cell death in the vector control (CI=0.47±0.15) but not in the p53 knockdown cells, as expected, while BV6+Ara-C was synergistic in both vector control and p53 knockdown cells (CI=0.15±0.03 and 0.08±0.03, respectively, 48 hours). BV-6 induced activation of caspase-8, caspase-9, and caspase-3 and decreased XIAP levels, but did not cause rapid cIAP1 degradation, as reported by others. To assess the contribution of death receptor-mediated apoptosis in BV-6-induced cell death, we treated Jurkat and caspase-8 mutated Jurkat cells (JurkatI9.2) with BV-6 and found that BV-6 induced cell death and significantly potentiated TRAIL-induced apoptosis in Jurkat cells (CI=0.14±0.08, 48 hours). Caspase-8 mutated JurkatI9.2 cells were significantly less sensitive to BV-6 than Jurkat cells and as expected, JurkatI9.2 was completely resistant to TRAIL. Collectively, we showed that the bivalent SMAC-mimetic BV-6 potentiates p53 activation-, chemotherapy-, and TRAIL-induced cell death, but has only minimal activity by itself in leukemic cells. SMAC-mimetics could be useful in enhancing the efficacy of different classes of therapeutic agents used in AML therapy. Disclosures: No relevant conflicts of interest to declare." @default.
• W2581748696 created "2017-02-03" @default.
• W2581748696 creator A5004888325 @default.
• W2581748696 creator A5032001891 @default.
• W2581748696 creator A5034434552 @default.
• W2581748696 creator A5075486072 @default.
• W2581748696 date "2010-11-19" @default.
• W2581748696 modified "2023-10-01" @default.
• W2581748696 title "SMAC-Mimetic BV-6 Sensitizes Therapeutic Agents-Induced Apoptosis In AML Cells" @default.
• W2581748696 doi "https://doi.org/10.1182/blood.v116.21.2177.2177" @default.
• W2581748696 hasPublicationYear "2010" @default.
• W2581748696 type Work @default.
• W2581748696 sameAs 2581748696 @default.
• W2581748696 citedByCount "2" @default.
• W2581748696 countsByYear W25817486962020 @default.
• W2581748696 countsByYear W25817486962022 @default.
• W2581748696 crossrefType "journal-article" @default.
• W2581748696 hasAuthorship W2581748696A5004888325 @default.
• W2581748696 hasAuthorship W2581748696A5032001891 @default.
• W2581748696 hasAuthorship W2581748696A5034434552 @default.
• W2581748696 hasAuthorship W2581748696A5075486072 @default.
• W2581748696 hasConcept C149150037 @default.
• W2581748696 hasConcept C153911025 @default.
• W2581748696 hasConcept C170301204 @default.
• W2581748696 hasConcept C190283241 @default.
• W2581748696 hasConcept C2777408456 @default.
• W2581748696 hasConcept C31573885 @default.
• W2581748696 hasConcept C33195913 @default.
• W2581748696 hasConcept C48297814 @default.
• W2581748696 hasConcept C502942594 @default.
• W2581748696 hasConcept C54355233 @default.
• W2581748696 hasConcept C55493867 @default.
• W2581748696 hasConcept C66008609 @default.
• W2581748696 hasConcept C81885089 @default.
• W2581748696 hasConcept C86803240 @default.
• W2581748696 hasConcept C95444343 @default.
• W2581748696 hasConcept C98424977 @default.
• W2581748696 hasConceptScore W2581748696C149150037 @default.
• W2581748696 hasConceptScore W2581748696C153911025 @default.
• W2581748696 hasConceptScore W2581748696C170301204 @default.
• W2581748696 hasConceptScore W2581748696C190283241 @default.
• W2581748696 hasConceptScore W2581748696C2777408456 @default.
• W2581748696 hasConceptScore W2581748696C31573885 @default.
• W2581748696 hasConceptScore W2581748696C33195913 @default.
• W2581748696 hasConceptScore W2581748696C48297814 @default.
• W2581748696 hasConceptScore W2581748696C502942594 @default.
• W2581748696 hasConceptScore W2581748696C54355233 @default.
• W2581748696 hasConceptScore W2581748696C55493867 @default.
• W2581748696 hasConceptScore W2581748696C66008609 @default.
• W2581748696 hasConceptScore W2581748696C81885089 @default.
• W2581748696 hasConceptScore W2581748696C86803240 @default.
• W2581748696 hasConceptScore W2581748696C95444343 @default.
• W2581748696 hasConceptScore W2581748696C98424977 @default.
• W2581748696 hasLocation W25817486961 @default.
• W2581748696 hasOpenAccess W2581748696 @default.
• W2581748696 hasPrimaryLocation W25817486961 @default.
• W2581748696 hasRelatedWork W1213497491 @default.
• W2581748696 hasRelatedWork W1970433780 @default.
• W2581748696 hasRelatedWork W1977327767 @default.
• W2581748696 hasRelatedWork W2014505287 @default.
• W2581748696 hasRelatedWork W2016446012 @default.
• W2581748696 hasRelatedWork W2037274375 @default.
• W2581748696 hasRelatedWork W2072621272 @default.
• W2581748696 hasRelatedWork W2101195593 @default.
• W2581748696 hasRelatedWork W2103092174 @default.
• W2581748696 hasRelatedWork W2134664407 @default.
• W2581748696 hasRelatedWork W2161574995 @default.
• W2581748696 hasRelatedWork W2321307348 @default.
• W2581748696 hasRelatedWork W2444657030 @default.
• W2581748696 hasRelatedWork W2484217008 @default.
• W2581748696 hasRelatedWork W2532056992 @default.
• W2581748696 hasRelatedWork W2557200531 @default.
• W2581748696 hasRelatedWork W2559924135 @default.
• W2581748696 hasRelatedWork W2581970586 @default.
• W2581748696 hasRelatedWork W2589720405 @default.
• W2581748696 hasRelatedWork W3012144647 @default.
• W2581748696 isParatext "false" @default.
• W2581748696 isRetracted "false" @default.
• W2581748696 magId "2581748696" @default.
• W2581748696 workType "article" @default.